top of page
Phone: 888-855-0947 Office Hours: M-F 10am-6pm Fax: 346-766-0599
After hours: If urgent, life threatening (please call 988, 911, or go to nearest ER. Otherwise, for side effects to medications, please text 816-766-0119. For all other non-urgent issues, please contact us Practice Q messaging portal or contact us during clinic hours at 888-855-0947.
Mental health providers
a women crying while holding a hand
a boy bow down on floor
Mental health providers
1/3
Ready for your Mental Health Transformation?
Child Psychiatrist /Adult Psychiatrist
Blog
Search
TBI Linked to Higher Risk for Schizophrenia, Bipolar Disorder
A history of traumatic brain injury (TBI) is associated with a 33% increased risk for schizophrenia and a 78% increase in bipolar...
Vilash Reddy, MD
Jun 20, 20243 min read
Childhood Physical Health and ADHD Symptoms
Keypoint: Do physical health conditions in childhood affect ADHD symptoms at age 17 years? Researchers investigated these associations in...
Vilash Reddy, MD
Jun 19, 20243 min read
Early-Life Exposure to Pollution Linked to Psychosis, Anxiety, Depression
Early-life exposure to air and noise pollution is associated with a higher risk for psychosis, depression, and anxiety in adolescence and...
Vilash Reddy, MD
Jun 14, 20243 min read
Why Generosity is a Psychoexemplary
PSYCHIATRIC VIEWS ON THE DAILY NEWS In his commencement speech at Brandeis, and as noted in our recent column on statesmanship, the...
Vilash Reddy, MD
Jun 11, 20242 min read
Neuroplasticity After Brain Injury: Principles and Methods for Postinjury Improvement
Keypoint: Improving cognitive function is a primary goal of brain injury rehabilitation and is made possible through the process of...
Vilash Reddy, MD
Jun 11, 20246 min read
Efficacy of Brexpiprazole and Sertraline for the Treatment of PTSD
Keypoint: A poster at the 2024 ASCP Annual Meeting shared data from 3 randomized clinical trials on the safety and tolerability of this...
Vilash Reddy, MD
Jun 7, 20243 min read
Polypharmacy in Older Adults
Keypoint: Clinicians should carefully weigh the risks and benefits of each prescribed medication for an older adult with neuropsychiatric...
Vilash Reddy, MD
Jun 7, 20247 min read
What to Expect if MDMA-Assisted Psychotherapy Gets Approved by the FDA
3,4-Methylenedioxymethamphetamine (MDMA) is a psychopharmacological agent with effects that include the enhancement of empathy, prosocial...
Vilash Reddy, MD
Jun 6, 20244 min read
Evaluating the Efficacy of Lumateperone for MDD and Bipolar Depression With Mixed Features
Keypoint: A poster presented at the 2024 ASCP Annual Meeting discussed the results of a study analyzing the treatment’s safety and...
Vilash Reddy, MD
Jun 6, 20243 min read
Critical Care Psychiatry: The Value of Psychiatrists in the ICU
Keypoint: In this CME article, learn more about common clinical conditions, consultation questions, and challenges in the field of...
Vilash Reddy, MD
Jun 5, 202413 min read
Teen Cannabis Use Tied to Dramatic Increased Risk for Psychosis
Teenagers who use cannabis have a dramatic increased risk for a psychotic disorder compared with their counterparts who don't use the...
Vilash Reddy, MD
Jun 5, 20243 min read
Physician Burnout by Specialty & Other Physician Mental Health Statistics
In the wake of the COVID-19 pandemic, physicians continue to experience burnout at alarmingly high rates. In a recent survey of 2440...
Vilash Reddy, MD
Jun 5, 20244 min read
Promising Topline Results for Drug to Treat Concomitant Depression and Insomnia
Seltorexant, an investigational drug being developed by Johnson & Johnson, met all primary and secondary endpoints in a phase 3 trial of...
Vilash Reddy, MD
Jun 4, 20242 min read
Revisiting Modafinil/Armodafinil for the Treatment of Bipolar Disorder
Keypoint: An expert shares some lessons learned from prior research on the treatment and suggestions for a way forward at the 2024 ASCP...
Vilash Reddy, MD
Jun 4, 20243 min read
Neuropsychiatric Symptoms an Important, Overlooked Feature of Lupus
Neuropsychiatric symptoms, including nightmares and hallucinatory "daymares," may be a more important aspect of systemic lupus...
Vilash Reddy, MD
Jun 4, 20248 min read
DOJ Officially Moves to Reclassify Marijuana as Schedule III
The US Department of Justice (DOJ) officially moved to reclassify marijuana as a Schedule III controlled substance on Thursday, marking a...
Vilash Reddy, MD
Jun 3, 20242 min read
New Data on Psychiatric Polypharmacy and Unwanted Weight Gain
Keypoint: A recent study analyzed longitudinal data of patients with schizophrenia or major depressive disorder to rank treatment...
Vilash Reddy, MD
May 30, 20243 min read
Longitudinal Study Looks at Risk of Cardiovascular Disease With Long-Term ADHD Medication Use
Keypoint: A study assessed the associations between the use of ADHD medications and CVD over the course of 14 years. Here's what the...
Vilash Reddy, MD
May 30, 20244 min read
When It Comes to Medicine, ‘Women Are Not Small Men’
Welcome everyone. I'm Dr. John White. I'm the chief medical officer at WebMD. Does your biologic sex impact your health? Does it have any...
Vilash Reddy, MD
May 30, 20245 min read
Polypharmacy in Traumatic Brain Injury
Keypoint:Polypharmacy is often overlooked in patients with significant traumatic brain injury. How can you best manage medication in...
Vilash Reddy, MD
May 29, 20244 min read
bottom of page